Leflunomide
-
Catalog number1972-50
-
PricePlease ask
-
Size50 mg
-
-
Alternative_name5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide), N-(4-Trifluoromethylphenyl)-5-methylisoxazol-4-carboxamide; HWA486,
-
DescriptionCell-permeable. An immunosuppressive agent. Inhibits T and B cell responses in vivo. Inhibitor of tyrosine phosphorylation (tyrosine kinase inhibitor), of dihydroorotate dehydrogenase, an enzyme for de novo pyrimidine synthesis, of TNF-dependent NF-κB activation, and of COX-2. The physiological activity of leflunomide is attributed mainly to its metabolite A77 1726.
-
CAS Number75706-12-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₂H₉F₃N₂O₂
-
Molecular Weight270.21
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (100 mM) or Ethanol (100 mM)
-
HandlingProtect from light and air
-
Tag LineAn immunosuppressant and a Tyrosine kinase inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life48 months
-
MDL NumberMFCD00867593
-
PubChem CID3899
-
SMILESCC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
-
InChiInChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13, 14)15/h2-6H,1H3,(H,17,18)
-
InChi KeyVHOGYURTWQBHIL-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameLeflunomide
-
Alternative nameLeflunomide
-